Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
79.31
-0.69 (-0.86%)
At close: Mar 4, 2026, 4:00 PM EST
80.89
+1.58 (1.99%)
After-hours: Mar 4, 2026, 4:57 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $777.2 million as of March 4, 2026. Its market cap has increased by 160.33% in one year.
Market Cap
777.20M
Enterprise Value
712.19M
1-Year Change
160.33%
Ranking
Category
Stock Price
$79.31
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $777.20M, an increase of 1,760.09%. That is a compound annual growth rate of 78.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 777.20M | 23.92% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 831.73M |
| CytomX Therapeutics | 831.08M |
| KalVista Pharmaceuticals | 818.98M |
| Omeros | 818.90M |
| MapLight Therapeutics | 812.17M |
| BridgeBio Oncology Therapeutics | 808.29M |
| Gyre Therapeutics | 759.84M |
| Prime Medicine | 759.67M |